Adverse event reports following vaccination for Lyme disease: December 1998–July 2000
- 28 December 2001
- Vol. 20 (11-12), 1603-1608
- https://doi.org/10.1016/s0264-410x(01)00500-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An overview of the vaccine adverse event reporting system (VAERS) as a surveillance systemVaccine, 1999
- THE FACIAL NERVEMedical Clinics of North America, 1999
- Influence of Outer Surface Protein A Antibody onBorrelia burgdorferiwithin Feeding TicksInfection and Immunity, 1999
- Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with AdjuvantNew England Journal of Medicine, 1998
- Descriptive epidemiology of adverse events after immunization: Reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994The Journal of Pediatrics, 1997
- Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.The Journal of Experimental Medicine, 1996
- The reporting sensitivities of two passive surveillance systems for vaccine adverse events.American Journal of Public Health, 1995
- Treatment of lyme arthritisArthritis & Rheumatism, 1994
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferiInfection and Immunity, 1993